Feasibility of a Newborn Screening for Spinal Muscular Atrophy (SMA) in France: DEPISMA Prefigurator Project in Grand-Est and Nouvelle-Aquitaine
Condition:   Feasibility of Neonatal Screening for Spinal Amyotrophy Intervention:   Sponsor:   University Hospital, Strasbourg, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials

Ultrasound-assisted or Landmark-based Intrathecal Administration of Nusinersen in Adult Patients With Spinal Muscular Atrophy (The EchoSpin Study)
Conditions:   Anesthesia, Spinal;   Spinal Puncture Complications;   Spinal Muscular Atrophy;   Ultrasonography Interventions:   Procedure: Interlaminar ultrasound-assisted intrathecal administration of nusinersen;   Procedure: Landmark-based intrathecal administration of nusinersen Sponsor:   Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials

Feasibility of a Newborn Screening for Spinal Muscular Atrophy (SMA) in France: DEPISMA Prefigurator Project in Grand-Est and Nouvelle-Aquitaine
Condition:   Feasibility of Neonatal Screening for Spinal Amyotrophy Intervention:   Sponsor:   University Hospital, Strasbourg, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials

Ultrasound-assisted or Landmark-based Intrathecal Administration of Nusinersen in Adult Patients With Spinal Muscular Atrophy (The EchoSpin Study)
Conditions:   Anesthesia, Spinal;   Spinal Puncture Complications;   Spinal Muscular Atrophy;   Ultrasonography Interventions:   Procedure: Interlaminar ultrasound-assisted intrathecal administration of nusinersen;   Procedure: Landmark-based intrathecal administration of nusinersen Sponsor:   Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials

Feasibility of a Newborn Screening for Spinal Muscular Atrophy (SMA) in France: DEPISMA Prefigurator Project in Grand-Est and Nouvelle-Aquitaine
Condition:   Feasibility of Neonatal Screening for Spinal Amyotrophy Intervention:   Sponsor:   University Hospital, Strasbourg, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials